Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Prostaglandins and Medicine
|
October 1, 1978
Redistribution of intrarenal blood flow following ADH administration: lack of inhibition by blockade of prostaglandin in cyclooxygenase
L A Walker, J G Gerber, J C Frolich, et al.
Prostaglandins
|
September 1, 1991
Metabolism of cysteinyl leukotrienes by the isolated perfused rat kidney
J Fauler, A Wiemeyer, M Yoshizawa, et al.
Prostaglandins
|
February 1, 1976
Quantifications of the major urinary metabolite of the E prostaglandins by mass spectrometry: evaluation of the method's application to clinical studies
H W Seyberth, B J Sweetman, J C Frolich, et al.
European Journal of Clinical Pharmacology
|
November 9, 2001
Availability of medicines in the European Union: results from the EURO-Medicines project
P Folino-Gallo, T Walley, J C Frolich, et al.
Prostaglandins
|
July 1, 1975
Assessment of the levels of pga2 in human plasma by gas chromatography-mass spectrometry
J C Frolich, B J Sweetman, K Carr, et al.
Prostaglandins
|
March 1, 1973
Quantitative vapor-phase analysis of prostaglandin F2 in female human urine
B J Sweetman, J T Watson, K Carr, et al.
Prostaglandins
|
January 1, 1977
Prostaglandins and renin release: I. Stimulation of renin release from rabbit renal cortical slices by PGI2
A R Whorton, K Misono, J Hollifield, et al.
Analytical Chemistry
|
October 1, 1973
Display-oriented data system for multiple ion detection with gas chromatography-mass spectrometry in quantifying biomedically important compounds
J T Watson, D R Pelster, B J Sweetmen, et al.
Clinical and Experimental Pharmacology & Physiology
|
January 1, 1996
Urinary NO3- excretion as an indicator of nitric oxide formation in vivo during oral administration of L-arginine or L-name in rats
R H Boger, S M Bode-Boger, U Gerecke, et al.
The Journal of Clinical Investigation
|
December 15, 1996
Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study
R H Böger, C Skamira, S M Bode-Böger, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Prostaglandins and Medicine
|
October 1, 1978
Redistribution of intrarenal blood flow following ADH administration: lack of inhibition by blockade of prostaglandin in cyclooxygenase
L A Walker, J G Gerber, J C Frolich, et al.
Prostaglandins
|
September 1, 1991
Metabolism of cysteinyl leukotrienes by the isolated perfused rat kidney
J Fauler, A Wiemeyer, M Yoshizawa, et al.
Prostaglandins
|
February 1, 1976
Quantifications of the major urinary metabolite of the E prostaglandins by mass spectrometry: evaluation of the method's application to clinical studies
H W Seyberth, B J Sweetman, J C Frolich, et al.
European Journal of Clinical Pharmacology
|
November 9, 2001
Availability of medicines in the European Union: results from the EURO-Medicines project
P Folino-Gallo, T Walley, J C Frolich, et al.
Prostaglandins
|
July 1, 1975
Assessment of the levels of pga2 in human plasma by gas chromatography-mass spectrometry
J C Frolich, B J Sweetman, K Carr, et al.
Prostaglandins
|
March 1, 1973
Quantitative vapor-phase analysis of prostaglandin F2 in female human urine
B J Sweetman, J T Watson, K Carr, et al.
Prostaglandins
|
January 1, 1977
Prostaglandins and renin release: I. Stimulation of renin release from rabbit renal cortical slices by PGI2
A R Whorton, K Misono, J Hollifield, et al.
Analytical Chemistry
|
October 1, 1973
Display-oriented data system for multiple ion detection with gas chromatography-mass spectrometry in quantifying biomedically important compounds
J T Watson, D R Pelster, B J Sweetmen, et al.
Clinical and Experimental Pharmacology & Physiology
|
January 1, 1996
Urinary NO3- excretion as an indicator of nitric oxide formation in vivo during oral administration of L-arginine or L-name in rats
R H Boger, S M Bode-Boger, U Gerecke, et al.
The Journal of Clinical Investigation
|
December 15, 1996
Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study
R H Böger, C Skamira, S M Bode-Böger, et al.
Page
of 3